Cardiopulmonary exercise testing during follow-up after acute pulmonary embolism.

"Conflicts of interest: S. Barco reports grants or contracts from Bayer, INARI, Boston Scientific, Medtronic, Bard, Sanofi and Concept Medical, consulting fees from INARI, payment or honoraria from INARI, Boston Scientific and Concept Medical, and support for attending meetings and/or travel from Bayer and Daiichi Sankyo. R. Ewert reports lecture fees from Boehringer Ingelheim, OMT, Novartis, Janssen-Cilag, United Therapeutics, AstraZeneca and Berlin-Chemie, research funding from Boehringer Ingelheim, OMT and Janssen-Cilag, and consulting fees from BetaPharm, OMT and Lungpacer Medical. G. Giannakoulas reports personal lecture/advisory fees from Bayer HealthCare, Pfizer and LeoPharma. L. Hobohm reports consulting fees and lecture honoraria from MSD and Janssen. S. Rosenkranz reports grants or contracts from Actelion, AstraZeneca, Bayer, Janssen and Novartis, consulting fees from Abbott, Acceleron, Actelion, Bayer, Janssen, MSD, Novartis, Pfizer, United Therapeutics and Vifor, and payment or honoraria from Actelion, Bayer, BMS, Ferrer, GlaxoSmithKline, Janssen, MSD, Novartis, Pfizer, United Therapeutics and Vifor. T.A. Morris reports research funding from INARI. S.V. Konstantinides reports grants or contracts from Bayer AG, consulting fees from Bayer AG, Daiichi Sankyo and Boston Scientific, and payment or honoraria from Bayer AG, INARI Medical, MSD, Pfizer and BMS. M. Held reports honoraria for lectures and advisory board activities from AstraZeneca, Bayer HealthCare, Berlin-Chemie, Boehringer Ingelheim, BMS, Daichi Sankyo, Janssen, MSD, OMT, Pfizer and Santis. D. Dumitrescu reports honoraria for lectures or consulting fees from Actelion, Bayer, Boehringer Ingelheim Pharma, GlaxoSmithKline, Janssen, MSD, Novartis, OMT, Pfizer, Servier and Vifor. The remaining authors disclose no potential conflicts of interest."

"Support statement: This cohort study used data from the FOllow-up after aCUte pulmonary emboliSm (FOCUS) study. FOCUS is an independent, investigator-initiated study with an academic sponsor (University Medical Center of the Johannes Gutenberg University, Mainz, Germany). The work of S.V. Konstantinides and S. Barco was supported by the German Federal Ministry of Education and Research (BMBF 01EO1003 and 01EO1503). In addition, the sponsor received a grant from Bayer AG. The funding bodies had no influence on the design or conduct of the study; collection, management, analysis or interpretation of the data; preparation, review or approval of the manuscript; or the decision to submit the manuscript for publication. Funding information for this article has been deposited with the Crossref Funder Registry."

"This work was registered with the German Clinical Trials Register (DRKS) with identifier DRKS00005939. Proposals for data access will be considered in accordance with the data access policy of the study sponsor (University Medical Center of the Johannes Gutenberg University, Mainz, Germany)."